Molecular Model of Prion Transmission to Humans
Author Information
Author(s): Michael Jones, Darren Wight, Rona Barron, Martin Jeffrey, Jean Manson, Christopher Prowse, James W. Ironside, Mark W. Head
Primary Institution: University of Edinburgh
Hypothesis
To assess interspecies barriers to transmission of transmissible spongiform encephalopathies, we investigated the ability of disease-associated prion proteins (PrPd) to initiate conversion of the human normal cellular form of prion protein of the 3 major PRNP polymorphic variants in vitro.
Conclusion
The study suggests that the conformation of a TSE agent’s PrPd plays a significant role in determining the susceptibility of a host’s PrPC to conversion.
Supporting Evidence
- The study demonstrated that the efficiency of prion amplification varies based on the genetic background of the substrate used.
- PrPd conformers associated with bovine BSE, ovine BSE, and human vCJD were amplified in humanized mouse substrates.
- Ovine scrapie PrPd could not be amplified in humanized mouse substrates but could be in sheep brain substrates.
Takeaway
This study looks at how prions, which cause certain diseases, can jump from animals to humans and how different genetic factors affect this process.
Methodology
The study used protein misfolding cyclic amplification (PMCA) to amplify prion proteins from various sources and assess their ability to convert normal prion proteins.
Limitations
The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website